We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




The Expanding European Market for Immunodiagnostics

By Labmedica staff writers
Posted on 11 Oct 2006
The immunodiagnostics market in Europe is expanding because of constant improvements in instrument capabilities and broad test menus. More...
A recent report from Frost & Sullivan (Palo alto, CA, USA) has found that the European immunodiagnostics automation markets earned revenues of U.S.$425 million in 2005, and estimates that this will reach $599.7 million in 2012.

The wide range of integrated analyzers has significantly improved profitability and revenue returns, but declining reimbursement rates and the lack of common industry standards for immunodiagnostic tests may hinder market expansion. This situation will compel in vitro diagnostics (IVD) manufacturers to design innovative strategies.

The need to accommodate and automate increasing test menus is motivating vendors to develop instrument capabilities that can meet modern clinical needs. In addition, growing volumes of tests are obliging laboratories to switch to high throughput systems, which are supporting the adoption and replacement of immunodiagnostic systems.

"The identification of new disease states and expanding test menus are key to market growth,” noted Frost & Sullivan research associate A.K. Arun. "An emphasis on achieving enhanced quality of healthcare is driving researchers to develop cost-effective diagnostic tests that provide better clinical outcomes, propelling the placement rates of analyzers.”

Although the need for, and value of, standardization and validation of assays has been recognized, it will still be necessary to accelerate this process in order to regulate immunodiagnostic procedures. The IVD industry needs to liaise with healthcare officials, the government, and medical communities to highlight the importance of diagnostic tests and appropriate reimbursement.



Related Links:
Frost & Sullivan

New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.